Peripheral Arterial Disease in Patients With Acute Coronary Syndrome: Results From a Large Real-World Registry

Crawford, 2016, Ankle brachial index for the diagnosis of lower limb peripheral arterial disease, Cochrane Database Syst Rev, 9, CD010680 Mahoney, 2010, Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States, Circ Cardiovasc Qual Outcomes, 3, 642, 10.1161/CIRCOUTCOMES.109.930735 Aronow, 1994, Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age, Am J Cardiol, 74, 64, 10.1016/0002-9149(94)90493-6 Criqui, 1992, Mortality over a period of 10 years in patients with peripheral arterial disease, N Engl J Med, 326, 381, 10.1056/NEJM199202063260605 Wilson, 2019, An international model to predict recurrent cardiovascular disease, Am J Med, 125, 695, 10.1016/j.amjmed.2012.01.014 Hussein, 2011, Peripheral arterial disease and progression of coronary atherosclerosis, J Am Coll Cardiol, 57, 1220, 10.1016/j.jacc.2010.10.034 Rein, 2015, Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease, Atherosclerosis, 239, 299, 10.1016/j.atherosclerosis.2015.01.021 Brevetti, 2010, Inflammation in peripheral artery disease, Circulation, 122, 1862, 10.1161/CIRCULATIONAHA.109.918417 Burek, 1999, Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI), J Am Coll Cardiol, 34, 716, 10.1016/S0735-1097(99)00262-4 Grenon, 2013, Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study, Vasc Med, 18, 176, 10.1177/1358863X13493825 Lee, 2013, Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease, JACC Cardiovasc Interv, 6, 1303, 10.1016/j.jcin.2013.08.008 Mukherjee, 2003, Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2]), Am J Cardiol, 92, 972, 10.1016/S0002-9149(03)00981-0 Saw, 2006, The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials, J Am Coll Cardiol, 48, 1567, 10.1016/j.jacc.2006.03.067 Makowsky, 2008, Lower extremity peripheral arterial disease in individuals with coronary artery disease: Prognostic importance, care gaps, and impact of therapy, Am Heart J, 155, 348, 10.1016/j.ahj.2007.09.005 Morillas, 2009, Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome, Am J Cardiol, 104, 1494, 10.1016/j.amjcard.2009.07.014 Cordeiro, 2018, Short-term prognostic effect of prior cerebrovascular and peripheral artery disease in patients with acute coronary syndrome: can we do better?, Eur Heart J Acute Cardiovasc Care, 7, 652, 10.1177/2048872617716388 Bhatt, 2009, Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes, Eur Heart J, 30, 1195, 10.1093/eurheartj/ehp099 Guerrero, 2005, Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database), Am J Cardiol, 96, 649, 10.1016/j.amjcard.2005.04.037 Cotter, 2003, Am Heart J, 145, 622, 10.1067/mhj.2003.6 Steg, 2007, One-year cardiovascular event rates in outpatients with atherothrombosis, JAMA, 297, 1197, 10.1001/jama.297.11.1197 van Werkum, 2009, Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry, J Am Coll Cardiol, 53, 1399, 10.1016/j.jacc.2008.12.055 Bonaca, 2018, Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: Insights from the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk), Circulation, 137, 338, 10.1161/CIRCULATIONAHA.117.032235 Bonaca, 2016, Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease, J Am Coll Cardiol, 67, 2719, 10.1016/j.jacc.2016.03.524 Chang, 2006, Ankle-arm index as a predictor of lesion morphology and risk classification for coronary artery disease undergoing angioplasty, Int J Cardiol, 113, 385, 10.1016/j.ijcard.2005.11.102 Otah, 2004, Usefulness of an abnormal ankle-brachial index to predict presence of coronary artery disease in African-Americans, Am J Cardiol, 93, 481, 10.1016/j.amjcard.2003.10.050 Spencer, 2007, Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting, Am Heart J, 153, 140, 10.1016/j.ahj.2006.09.009 Brevetti, 2008, In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction, Atherosclerosis, 201, 440, 10.1016/j.atherosclerosis.2008.01.014 Nicholls, 2005, Myeloperoxidase and cardiovascular disease, Arterioscler Thromb Vasc Biol, 25, 1102, 10.1161/01.ATV.0000163262.83456.6d Cassar, 2003, Platelet activation is increased in peripheral arterial disease, J Vasc Surg, 38, 99, 10.1016/S0741-5214(03)00129-0 Gremmel, 2014, Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty, Atherosclerosis, 232, 119, 10.1016/j.atherosclerosis.2013.10.027 Eikelboom, 2017, Rivaroxaban with or without aspirin in stable cardiovascular disease, N Engl J Med, 377, 1319, 10.1056/NEJMoa1709118